Yersinia pestis infection cost-effectiveness of therapy: Difference between revisions
No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Yersinia pestis infection}} | {{Yersinia pestis infection}} | ||
{{CMG}}; {{AE}} {{JS}} | |||
==Overview== | |||
==References== | ==References== | ||
Line 14: | Line 15: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 19:34, 25 July 2014
Yersinia pestis infection Microchapters |
Differentiating Yersinia Pestis Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Yersinia pestis infection cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Yersinia pestis infection cost-effectiveness of therapy |
FDA on Yersinia pestis infection cost-effectiveness of therapy |
CDC on Yersinia pestis infection cost-effectiveness of therapy |
Yersinia pestis infection cost-effectiveness of therapy in the news |
Blogs on Yersinia pestis infection cost-effectiveness of therapy |
Risk calculators and risk factors for Yersinia pestis infection cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]